← Back to headlines
WHO Prequalifies Novartis’ Coartem Baby for Infant Use
The World Health Organization has prequalified Novartis' Coartem Baby, an antimalarial drug, for use in infants, marking a significant step in combating malaria in young children.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
